386999001: Poractant alfa (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Surfactant (substance)\Lung surfactant\Poractant alfa (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Respiratory system agent (substance)\Lung surfactant\Poractant alfa (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Lipoprotein\Lung surfactant\Poractant alfa (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Lipoprotein\Lung surfactant\Poractant alfa (substance)
\Organic compound\Lipid\Lipoprotein\Lung surfactant\Poractant alfa (substance)

\Biological substance\Protein and/or protein derivative\Protein\Lipoprotein\Lung surfactant\Poractant alfa (substance)
\Biological substance\Polypeptide\Protein\Lipoprotein\Lung surfactant\Poractant alfa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461177011 Poractant alfa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481113011 Poractant alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

7449751000241111 poractant alfa fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Poractant alfa (substance)	Is a	Lung surfactant	true	Inferred relationship	Some
Poractant alfa (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some
Poractant alfa (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Surfactant (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing poractant alfa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poractant alfa (substance)	Inferred relationship	Some	1
Phospholipid fraction allergy	Causative agent (attribute)	False	Poractant alfa (substance)	Inferred relationship	Some
Poractant alfa 120mg/1.5mL sterile suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Poractant alfa (substance)	Inferred relationship	Some
Poractant alfa 240mg/3mL sterile suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Poractant alfa (substance)	Inferred relationship	Some
Poractant alfa 80mg/mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Poractant alfa (substance)	Inferred relationship	Some
Phospholipid fraction adverse reaction	Causative agent (attribute)	False	Poractant alfa (substance)	Inferred relationship	Some	1
Phospholipid fraction allergy	Causative agent (attribute)	False	Poractant alfa (substance)	Inferred relationship	Some	1
Product containing precisely phospholipid (as poractant alfa) 240 milligram/3 milliliter conventional release suspension for endotracheopulmonary instillation vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Poractant alfa (substance)	Inferred relationship	Some	1
Product containing precisely phospholipid (as poractant alfa) 120 milligram/1.5 milliliter conventional release suspension for endotracheopulmonary instillation vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Poractant alfa (substance)	Inferred relationship	Some	1
Poractant alfa-containing product in pulmonary dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poractant alfa (substance)	Inferred relationship	Some	1
Product containing only poractant alfa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poractant alfa (substance)	Inferred relationship	Some	1
Poractant alfa only product in pulmonary dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poractant alfa (substance)	Inferred relationship	Some	1
Poractant alfa 80 mg/mL suspension for endotracheopulmonary instillation	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Poractant alfa (substance)	Inferred relationship	Some	1
Poractant alfa 80 mg/mL suspension for endotracheopulmonary instillation	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Poractant alfa (substance)	Inferred relationship	Some	1
Adverse reaction to poractant alfa (disorder)	Causative agent (attribute)	True	Poractant alfa (substance)	Inferred relationship	Some	1

Reference Sets

Description inactivation indicator reference set